Immunoglobulins Global Market Report 2021: COVID-19 Implications and Growth to 2025 & 2030 - ResearchAndMarkets.com

·4 min read

DUBLIN, December 02, 2021--(BUSINESS WIRE)--The "Immunoglobulins Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.

The global immunoglobulins market is expected to grow from $12.89 billion in 2020 to $14.56 billion in 2021 at a compound annual growth rate (CAGR) of 13%. The market is expected to reach $19.36 billion in 2025 at a CAGR of 7.4%.

The immunoglobulins market consists of sales of immunoglobulins by entities (organizations, sole traders, and partnerships) that are used to measure the level of types of antibodies in the blood. Immunoglobulins or antibodies are glycoprotein molecules generated by plasma cells (white blood cells). They are an important aspect of the immune response because they recognize and bind to certain antigens, such as bacteria or viruses, and help to destroy them.

The main types of products in immunoglobulins are IGG, IGA, IGM, IGE, and IGD. Immunoglobulin G (IGG) is the primary stimulator of humoral immunity in extracellular fluids such as blood, lymph, and saliva. The immunoglobulins are delivered using the intravenous mode of delivery, subcutaneous mode of delivery and are used in hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), others.

North America was the largest region in the immunoglobulins market in 2020. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. Major companies operating in the immunoglobulins sector are focused on opening new laboratories for immunoglobulins to enhance the platform technology, pipeline development, and manufacturing capabilities.

In June 2020, CSL Behring, a US-based biopharmaceutical company acquired Vitaeris Inc. for an undisclosed amount. This acquisition accelerates the addition of clazakizumab, an anti-IL6 MAB currently in phase III development for the treatment of chronic active antibody-mediated rejection, into CSL Behring's portfolio. Vitaeris Inc. is a US-based clinical-stage biotechnology company.

The increasing geriatric population drives the growth of the immunoglobulins market. The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body's ability to produce antibodies that protect it from bacteria, viruses, and allergies. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period.

Major players in the immunoglobulins market are

  • Baxter International Inc.

  • CSL Behring LLC

  • Grifols S.A.

  • Octapharma

  • China Biologic Products Inc.

  • Kedrion S.p.A.

  • LFB group

  • Biotest AG

  • Sanquin

  • ADMA Biologics

  • Option Care Enterprises

  • Shanghai Raas Blood Products Co. Ltd

Key Topics Covered:

1. Executive Summary

2. Immunoglobulins Market Characteristics

3. Immunoglobulins Market Trends and Strategies

4. Impact Of COVID-19 On Immunoglobulins

5. Immunoglobulins Market Size and Growth

5.1. Global Immunoglobulins Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Immunoglobulins Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Immunoglobulins Market Segmentation

6.1. Global Immunoglobulins Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • IGG

  • IGA

  • IGM

  • IGE

  • IGD

6.2. Global Immunoglobulins Market, Segmentation by Mode of Delivery, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Intravenous

  • Subcutaneous

6.3. Global Immunoglobulins Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Hypogammaglobulinemia

  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Immunodeficiency Disease

  • Myasthenia Gravis

  • Idiopathic Thrombocytopenic Purpura (ITP)

  • Others

7. Immunoglobulins Market Regional and Country Analysis

7.1. Global Immunoglobulins Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Immunoglobulins Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/51qkq1

View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005576/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting